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Background: Delayed motor development is reported in patients with congenital heart disease (CHD). Exercise is
widely used to facilitate motor development and improve motor ability. Exercise for adolescents and adults with
CHD has been extensively studied. However, the evidence of exercise for infants with CHD is sparse. This study aims
to identify the effect of passive movement and active exercise on motor development within very young CHD
infants with cardiac catheterization.
Methods/Design: A prospective and randomized controlled trial will be conducted in very young CHD infants with
cardiac catheterization. A total of 147 infants with CHD will be randomized by a 1:1:1 allocation ratio by computer
to an exercise intervention group, a home-based intervention group and a control group. The exercise intervention
group will receive passive movement and active exercise from experienced physiotherapists in pediatrics three
times a week for 12 weeks. The home-based intervention group will receive passive movement and active exercise
from their parents or caregivers at home three times a week for 12 weeks. The control group will receive follow up
only. The follow-up duration is 20 months. The primary outcome measures are the motor quotient measured by
the Peabody Developmental Motor Scales-II. The secondary outcome measures are the Ross score, ventricular
function, bone quality, body length, weight, head circumference, upper arm circumference, and adverse events.
Discussion: This study has several important features, including the randomization process, the long follow-up
duration, the control group, and the large sample size. The aim of this study is to determine whether 12-week
passive movement and active exercise promotes motor development and produces other beneficial effects for very
young CHD infants with cardiac catheterization. Therefore, this study will contribute new knowledge regarding the
rehabilitation program in very young CHD infants with cardiac catheterization.
Trial registration: Current Controlled Trials ChiCTR-IOR-15005909 (January 31, 2015).
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Congenital heart disease (CHD) is common in infants
[1]. The prevalence of CHD was 10.8-26.6‰ [2–4]. With
the improvement of echocardiography and medical
care, more patients with CHD were underwent cardiac
catheterization than ever before. Because of the high* Correspondence: sunkunxh@126.com
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creativecommons.org/publicdomain/zero/1.0/success rate, short hospital stay, low morbidity and mor-
tality, cardiac catheterization of CHD is favored over sur-
gery. Cardiac catheterizations have been used to treat
neonates with critical congenital heart disease, such as val-
var stenosis or atresia [5]. However, patients with CHD
frequently exhibit delayed neurodevelopmental function,
decreased exercise capacity, impaired exercise perform-
ance and lower health-related quality of life.
Pronounced delayed neurodevelopmental function has
been observed in children with CHD [6, 7], especially
those with cyanotic CHD [7] or catheterization [8] ordistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
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Lower exercise function [10, 11], dysfunction in speech
and language [12], poor cognitive function [13, 14] and
behavior difficulties [8] were also reported in pre-
school and school-age patients with CHD. The causes
of delayed neurodevelopmental function may include
hemodynamic defects, long-standing hypoxemia [7],
long hospital stay and physical inactivity (for example,
prolonged time in strollers and walkers). Inadequate
exercise for patients with CHD may lead to cardiovas-
cular complications. Therefore, infants with CHD re-
quire a large amount of physical activity to master
movement control.
The Cardiac Rehabilitation Program has been stud-
ied in adolescents and adults with CHD [15–17]. Exer-
cise is the core component of the cardiac rehabilitation
program and is safe, feasible and beneficial. Past stud-
ies have documented that exercise increases exercise
capacity [10, 18–20], HR recovery following peak exer-
cise [21], respiratory muscle oxygenation and health-
related quality of life [15, 16] in adolescents and adults
with CHD. In contrast, the use of the cardiac rehabili-
tation program and clinical research in pediatric popu-
lations have been limited [22]. There is only one study
of preschool children with CHD, which suggests that
the short low-dose intervention program can improve
motor ability and delayed motor development [23].
The optimal cardiac rehabilitation program of this
unique population is still unknown and needs to be
developed.
Performing exercises in infants with CHD remains
challenging. To date, there have been few rehabilita-
tion interventions that target infants with CHD. The
effect of exercise on motor development in infants
with CHD is unknown. Therefore, it is important to
identify passive movement and active exercise to facili-
tate motor development within this population. This
paper describes the rationale, design and methodology
of a randomized, controlled study being conducted in
China.
Methods/Design
A prospective and randomized controlled trial involving
passive movement and active exercise in very young
CHD infants with cardiac catheterization will be per-
formed. The aim of the study is to determine:
1) whether passive movement and active exercise
beginning at 1 month of corrected age (CA) in
infants with CHD improves motor development at
24 months of CA compared with control subjects,
2) the potential benefits of exercise on growth, heart
function and bone quality of very young infants with
CHD, and3) the potential adverse effects related to passive
movement and active exercise.
Study design
The CHD patients with cardiac catheterization will be
recruited from and investigated at the Xin Hua Hospital
affiliated to the Shanghai Jiao Tong University School of
Medicine, Shanghai City, China.
Prior to inclusion, the following information will be
obtained for all patients: demographic data (for ex-
ample, gestational age at birth, birth weight, CA, and
gender), medical history (for example, the duration of
intensive care unit and hospital stay, and age of cardiac
catheterization), heart defect (for example, defect type
and size), and type of feeding (for example, breast or
artificial feeding). Each patient’s parents will be asked
to sign an informed consent form before the patient
can participate in the study.
Eligible participants will be randomized by a 1:1:1
allocation ratio by computer either to the exercise
intervention group, in which they will receive passive
movement and active exercise to promote motor de-
velopment; the home-based intervention group, in
which they will receive passive movement and active
exercise from parents or caregivers at home; or the
control group, in which they receive follow up only
(Fig. 1). The total study duration will be 23 months,
which consists of a 3-month intervention and 20-
month follow-up period without intervention. All patients
will receive the exercise intervention, the home-based
intervention, or the control conditions as allocated.
All patients will be assessed at 1, 4, 6, 12 and 24
months CA.
If the pediatrician evaluating the patient prescribes
additional physiotherapy, the patient will receive physio-
therapy. The pediatrician will record information if the
participant receives other physiotherapy.
Participants
CHD patients with cardiac catheterization are eligible
for the study. Patients who meet the following inclusion
criteria will be enrolled:
1. infants with CHD,
2. less than 1 month CA,
3. with a modified Ross score of less than 3 points,
4. availability 5 days a week over a period of 12 weeks,
5. for whom informed parental consent has been
provided.
Patients who have any of the following exclusion cri-
teria will be excluded:
1. previous cardiac operation history;
Fig. 1 Flowchart. CHD indicates congenital heart disease; CA corrected age, PDMS-II Peabody Developmental Motor Scales-II
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disorder, or arrhythmia;
3. heart failure with a modified Ross score of 3 points
or more;
4. significant hemodynamic defects to make exercises
inadvisable; or
5. other congenital malformations.
Withdrawal management
The patients with CHD who have any of the following
conditions will be allowed or will be asked to withdraw
from the study:
1. The patient’s parents require withdrawal.2. The patient develops heart failure, or respiratory
failure, or other serious diseases.
3. The exercises lead to any adverse effects.
Ethical considerations
The ethics committee of Xin Hua Hospital affiliated to
the Shanghai Jiao Tong University School of Medicine
approved the study protocol (Approval No. XHEC-D-
2015-002). The ethics committee certified that this study
did not raise any issues of patients’ risk. The ethics com-
mittee also certified that the study was in accordance
with the Declaration of Helsinki and that the study was
conducted without ethics problems. The study protocol
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ChiCTR-IOR-15005909.
Recruitment process
Enrollment will take place at the pediatric cardiovascular
clinic of the Xin Hua Hospital. A pediatrician will evalu-
ate all of the eligible patients. Written informed consent
must be signed by the patients’ parents prior to enroll-
ment. Then, we will perform the baseline assessment.
Randomization process
The participants are randomly assigned to each group
after the baseline assessment, when the demographic
data are collected. We use concealed randomization as-
signment and an adequate computer-generated assign-
ment sequence to avoid selection bias. Thus, neither
investigators nor the participants’ parents can influence
which group the patients are assigned to.
Intervention group
Exercise will be provided for a 25-min period per day for
5 days a week over a period of 12 weeks, 1 h after feed-
ing by experienced pediatric physiotherapists. All infants
in this group will receive exercise in supine, prone,
side-lying, and supported-sitting positions. The specific
exercise protocol is selected based on previous studies
[24–30]. The exercise protocol consists of 25 minutes
of movements for very young infants, including passive
range-of-motion exercise, feet and hands reaching, and
exercises in prone, side-lying, and supported-sitting po-
sitions. Table 1 presents the details about the exercise
protocol. Experienced pediatric physiotherapists will
perform the exercise intervention. If the infant begins
to cry, the exercises will be stopped. Each infant will re-
ceive treatment from multiple physiotherapists to en-
sure that the treatment effects are the result of the
treatment protocol and not any particular provider.
Each infant will receive exercise in a random beginning
position and sequence of movements within each pos-
ition. The parents or caregivers will be asked to record
the level of compliance with the exercises each day.
The level of compliance will be scored using the follow-
ing categories [31]: tolerated movement well, tolerated
movement moderately well, refused to participate, or is
not present in the hospital.
Exercise in the supine position
Passive range-of-motion exercise
Previous studies have proven that passive range-of-
motion exercise with gentle joint compressions is benefi-
cial for weight gain [25, 32] and bone development [26,
33–36] in preterm infants. Consequently, effective pas-
sive exercise may be needed in infants with CHD. Each
infant will receive passive range-of-motion exercises withgentle joint compressions at the end of each movement.
We will perform 10 repetitions of passive range-of-motion
exercise on the wrists, elbows, shoulders, ankles, knees,
and hips. Each joint flexion/extension motion lasts for 5 s,
for a total period of 10 min.
Feet and hand reaching
Goal-directed reaching provides an early intervention
strategy to encourage movement in very young infants.
Studies have showed that feet and hand reaching train-
ing programs were beneficial for the preterm population
[27, 28, 37, 38]. Feet and hand reaching using a malle-
able rubber toy are designed to improve the ability of in-
fants to reach for toys with their feet or hands and
promotes the dissociation of the joints. Both feet and
hand reaching consists of toy-oriented reaching in three
movements by a physiotherapist, as described in a previ-
ous study [27, 38]. We will perform 2 repetitions. Each
movement lasts for approximately 30 s, for a total period
of 6 min.
Exercise in the prone position
The prone position is a very important position for in-
fants developing motor development. Young infants are
able to take advantage of the prone position to advance
their early motor development [39]. The exercises in
prone position are designed to develop antigravity move-
ments of the extremities, head control, weight bearing
on arm muscles, and strength for sitting. The exercises
in the prone position consist of two movements (Table 1)
as described in a previous study [29]. Each movement is
repeated four times. Each movement lasts for approxi-
mately 30 s, for a total period of 4 min.
Exercise in the side-lying position
Each infant will receive exercises in the side-lying pos-
ition. Infants will be placed in the side-lying position, in
which their hips and knees are flexed to approximately
110 degrees, their heads are slightly flexed forward, and
their upper extremities are protracted with their hands
placed at the midline. Exercises in the side-lying position
are designed to encourage visual awareness and midline
orientation of the upper extremities and to promote the
development of rolling over. Two movements based on
a previous study [30] will be performed in the side-lying
position (Table 1). Each movement is repeated ten times.
Each movement lasts for approximately 6 s, for a total
period of 2 min.
Exercise in the supported-sitting position
Infants will participate in supported-sitting position ex-
ercises. Exercises in the supported-sitting position are
designed to promote head and trunk control. Three
movements will be performed in the supported-sitting
Table 1 The exercise protocol for very young infants with CHD
Positions Movements Each time (s) Repetitions (n) Total time (s)
Supine Passive range-of-motion exercise
Flexing and extending each hand at the wrist 5 10 50
Flexing and extending each arm at the elbow 5 10 50
Flexing and extending each arm at the shoulder 5 10 50
Flexing and extending each foot at the ankle 5 10 50
Flexing and extending each leg at the knee 5 10 50
Flexing and extending each leg at the hip 5 10 50
Feet reaching to contact a midline toy
Holding the infant’s leg and directing the foot toward the toy in midline 30 2 60
Holding a stationary toy in midline within the infant’s visual field, and leading the
foot toward the toy for a few seconds to allow the infant to contact the toy
spontaneously. If the infant do not contact the toy spontaneously, the
physiotherapist performs tactile stimulation with the toy to the infant’s foot
30 2 60
Holding an infant’s hip at 90 degrees, holding a stationary toy within the infant’s
visual field, and encouraging the foot to contact the toy
30 2 60
Hand reaching to contact a midline toy
Holding the infant’s forearm and directing the hand toward the toy in midline 30 2 60
Performing tactile stimulation with the toy on one upper limb of the infant, taking
the toy to the midline, and waiting a few seconds to allow the infant to contact
the toy with the hand spontaneously
30 2 60
Holding a stationary toy in the midline within the infant’s visual field, and leading
the hand toward the toy for a few seconds to allow the infant to spontaneously
contact the toy. If the infant does not spontaneously contact the toy, the
physiotherapist performs tactile stimulation with the toy in the infant’s hand
30 2 60
Prone Prone on a ball: use elbows to support the weight and raise the head 30 4 120
Hand reaching to contact a toy slightly out of reach 30 4 120
Side-lying Anterior-posterior rocking: place hands on hips and on the shoulders and head;
slowly rock forward and backward
6 10 60
Lower trunk rotating: placing hands between lower extremities to control pelvis;
slowly rotate the pelvis on the upper trunk anteriorly and posteriorly
6 10 60
Supported-sitting Displacing the trunk slowly in anterior, posterior, and lateral directions, 30 degrees
from a vertical position. Place back upright to 20 degrees of a vertical position.
Head and upper trunk supported throughout entire displacement
6 10 60
Rotating the upper body slowly to each side with the head and upper extremities
supported; approximately 45 degrees of rotation
6 10 60
Supporting infant 20 degrees from a vertical position; placing index fingers on side
of head to control bobbing. Briefly removing head support to encourage head control.
6 10 60
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Each movement is repeated ten times. Each movement
lasts approximately 6 s, for a total period of 3 min.
Home-based intervention group
The exercise protocol for the home-based intervention
group is the same as that for the intervention group. Ex-
ercise intervention will be performed by parents or care-
givers. Before starting the home-based intervention, an
experienced pediatric physiotherapist will give a detailed
explanation of the aims, importance, methods, and pro-
cedure of home-based intervention to parents or care-
givers. Then, the physiotherapist will teach parents orcaregivers the exercises in the four different positions
until they perform all the items well. A brochure of
home-based intervention and a DVD with exercises
video will also be given to them. Parents or caregivers
will be asked to record the treatment items, the duration
of treatment and the infant’s reaction during the treat-
ment everyday. Physiotherapists will make a phone call
once a week to remind them of performing the exer-
cises, and get valuable information about the details of
home-based intervention. The level of compliance will
be scored using the following categories [31]: tolerated
movement well, tolerated movement moderately well, or
refused to participate.
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Each infant in the control group will receive no training.
All participants in the trial will receive health education.
This includes group counseling focusing on daily activity
and diet. The participants will be asked not to partici-
pate in any other rehabilitation treatments.
Outcome measures
The baseline and follow-up evaluations will be per-
formed by experienced pediatric assessors blinded to the
group assignments when the patient is at 1, 4, 6, 12 and
24 months CA.
Primary outcome measure
Motor development will be measured using the Peabody
Developmental Motor Scales-II (PDMS-II) via the motor
quotient. Motor development is measured at 1, 4, 6, 12
and 24 months CA with the PDMS-II by an assessor
blinded to the group assignments. The use of the PDMS-
II is recommended [40] and has been widely used as a
motor development outcome measure for patients with
CHD [41–46]. Both fine and gross motor function can be
assessed by the PDMS-II. The PDMS-II is valid for chil-
dren aged from term to 76 months. The PDMS-2 contains
six subtests, including reflexes, stationary, locomotion, ob-
ject manipulation, grasping and visual-motor integration.
The results of the subtests may be used to generate a
Gross Motor Quotient, a Fine Motor Quotient and a Total
Motor Quotient, which are three global indices of motor
development. A previous study demonstrated that the
PDMS-II had high test-retest reliability and acceptable re-
sponsiveness to intervention effects [47].
Secondary outcome measures
1. The Ross score will be evaluated using a modified
Ross scoring system. The Ross scoring system [48]
was first described by Ross [49] for infants. Then,
Reithmann et al. [50] and Läer et al. [51] modified
the system. The modified Ross scoring system is
used in the clinical evaluation of patients with CHD.
It consists of diaphoresis, tachypnea, breathing with
abdominal retractions, respiratory rate, heart rate,
and hepatomegaly. Each variable receives a score of
0, 1, or 2 points according to severity. The range of
the total score is from 0 to 12 points with higher
values indicating more severe impact. An experienced
pediatric cardiologist grades the six variables.
2. Ventricular function will be assessed using
echocardiography, which is a useful noninvasive
method. In patients with CHD, the measurement of
ventricular function using echocardiography is a
standard procedure [52]. The left ventricular function
is an important variable. The most commonly utilizedindices of the left ventricular function are the left
ventricular ejection fraction and fractional shortening
[48]. Echocardiographic assessment of the patients is
performed by an experienced pediatric cardiologist.
Echocardiographic assessment of crying children is
performed approximately 5 minutes after they become
calm.
3. Bone quality will be measured using a quantitative
ultrasound machine (Omnisense 7000P, Sunlight
Medical Inc., Israel). Quantitative ultrasound
measurements provide a safe, non-invasive method
for obtaining information on bone quality. The
quantitative ultrasound method is designed to measure
the speed of sound (SOS) at a peripheral site (such as
the distal 1/3 of the radius and middle of the tibia [53])
by axial transmission. The measurement site is defined
as the distal 1/3 of the radius. The mean of three
measurements of the radius SOS is used for analysis.
The z-score is given in terms of the standard deviation
from the average of population of same age and
gender. The z-score is defined as the difference
between the raw score to be standardized and the
mean difference divided by the standard deviation
(a z-score less than or equal to −2.0 indicates low bone
quality and a z-score greater than −2 indicates normal
bone quality). The z-score is predictive of bone quality
in children [54, 55]. All quantitative ultrasound
measurements are performed by the same trained
pediatrician.
4. Anthropometric measurements, including body
length, weight, head circumference and upper arm
circumference, will be measured. Body length is
measured without shoes. Weight is measured with
light clothing using digital scale (Seca Digital Column
Scale and Seca 376 Baby Scale). Head circumference
and upper arm circumference are measured with a
nonflexible tape.
5. Adverse events related to exercise will be recorded.
Sample size calculation
We used GPower3.1.9.2 to perform the power calculation.
Our primary outcome measure is the motor quotient
measured on the PDMS-II. A difference of the motor quo-
tient score among the three groups of 0.5 SD is considered
to be clinically significant. Thus, we must recruit 42 in-
fants in each group to have an 80% chance of detecting
this difference among the three groups with a significance
level of 0.05 (alpha) on two-sided tests. Considering po-
tential attrition, 49 infants in each group will be recruited.
Statistical analysis
The SPSS 20.0 and Microsoft Excel 2013 software will be
used for statistical analyses. Demographic data will be de-
scribed with descriptive statistics, including the mean ±
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to compare the primary and secondary outcomes of the
three groups. A general linear model will be used to com-
pute mean outcome values adjusted for diagnosis, gender
and socioeconomic status (SES), with the group as the
fixed factor and diagnosis, gender and SES as covariates. If
patients are lost to follow-up, an intention-to-treat analysis
will be performed. Statistical significance is set at a p-value
less than 0.05.
Discussion
According to previous studies, exercise is an effective
treatment for adolescents and adults with CHD. However,
the evidence of the effects of exercise for CHD infants
with cardiac catheterization is sparse. We will perform a
prospective randomized-controlled trial of passive move-
ment and active exercise for very young CHD infants with
cardiac catheterization. The chosen method seems safe,
applicable and feasible to very young infants with CHD.
The study may provide evidence that passive movement
and active exercise offer an alternative treatment for very
young infants with CHD. Passive movement and active ex-
ercise may have some beneficial effects for infants with
CHD by promoting motor development and growth, and
improving heart function and bone quality.
This study has some strengths. First, the follow-up dur-
ation in most previous exercise studies typically ranged
from 12 weeks [23] to 1 year [20]. In this study, the total
study period is 23 months, with an intervention duration
of 12 weeks and a follow-up duration (with no active
intervention) of 20 months. Second, in this study, the
intervention group performs exercises with the assistance
of experienced pediatric physiotherapists, meanwhile the
home-based intervention group performs exercises with
the assistance of parents or caregivers, but the control
group receives no training. Therefore, compared to previ-
ous studies [18–20, 23], our study could reduce biases.
Third, a power calculation is performed for this study.
The total number of patients enrolled in the study is 147.
Fourth, previous studies have mainly focused on exercise
capacity [10, 18–20] and motor development [23]. Heart
function and bone quality are rarely analyzed following
passive movement and active exercises in patients with
CHD. However, there are some limitations in our study.
The spontaneous daily activities outside the study exer-
cises are not monitored. Parents or caregivers may alter
their infants’ daily activities, which would influence motor
development.
Trial status
Subject recruitment is underway.
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